Nottingham City Hospital — Nottingham

Public research footprint of Nottingham City Hospital, compiled from the ClinicalTrials.gov public registry.

291

Registered studies

Active

Recruiting now

159

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Multiple Myeloma · Squamous Cell Carcinoma of Head and Neck · Recurrent Ovarian Low Grade Serous Adenocarcinoma

Recently updated registry entries

NCT07226843 — A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers (Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT02101788 — Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nottingham City Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.